Interstitial lung disease (ILD) is a rare complication of methotrexate (MTX) treatment. It usually develops during the first 6 months of treatment but later occurrences have been described (1, 2). ...
No takes yet. Share an insight, caveat, or question.
Rutanen et al. (2014) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: